Allyl Isothiazole

Production-scale synthesis of N-allylisothiazolin-3-one (NAIT) via electrophilic chlorination of allyl isothiazole in a recirculating batch reactor remains the dominant industrial route for non-formaldehyde-releasing can preservatives. In a typical campaign at a 5,000 L glass-lined reactor equipped with an external plate heat exchanger and a submerged chlorine sparger, allyl isothiazole (CAS 5146-38-4) is first dissolved in anhydrous ethyl acetate to a final concentration of 1.8 mol/L. The reactor contents are cooled to −5 °C while gaseous chlorine, pre-dried through a sulfuric acid scrubber, is introduced at a rate controlled to maintain a solution redox potential of +720 mV (Ag/AgCl). The molar feed ratio of allyl isothiazole to Cl₂ is locked at 1.00:1.08; deliberate overfeeding of chlorine by 8 mol% accounts for evaporative loss and the formation of a transient N-chloro intermediate that dehydrohalogenates to the isothiazolinone ring. Post-reaction monitoring by inline Raman spectroscopy tracks the disappearance of the characteristic isothiazole ring breathing mode at 1,360 cm⁻¹, and the batch is terminated when residual allyl isothiazole drops below 0.5% of initial charge. Unreacted Cl₂ is quenched by sodium sulfite addition at a molar ratio of 1.2:1 (sulfite to residual oxidant), and the crude NAIT solution is vacuum-distilled at 45 °C and 25 mbar to a neat assay of ≥98.5% (GC-FID).

A recurrent production bottleneck arises during the quenching step: alkaline sulfite addition can trigger premature ring-opening hydrolysis of NAIT if the solution temperature momentarily exceeds 15 °C, generating 3-mercapto-N-allylpropanamide, which acts as a catalyst poison in the subsequent formulation tank. Consequently, all production campaigns implement a jacket-temperature interlock set to −2 °C during quenching, and the batch record logs a time-temperature integrator F-value of ≤0.3 min⁻¹ for thermal degradation. For downstream formulation as a ready-to-use paint-can biocide, NAIT is blended with a stabilizer cocktail—typically 0.35 wt% copper(II) nitrate trihydrate and 0.12 wt% benzisothiazolinone (BIT) as synergist—and diluted with dipropylene glycol monomethyl ether (DPM) to a final active content of 1.5% (ISO 11930:2019 challenge test effective dose: 0.08% product in white interior emulsion, yielding a 50 ppm active concentration in-wet paint). The formulated biocide must comply with the active substance approval under the EU Biocidal Products Regulation (EU) 528/2012 Annex I, listing NAIT under PT 6 (preservatives for products during storage) and PT 13 (metalworking fluid preservatives), and requires a valid Article 95 supplier listing. For North American markets, the formulation is registered under US EPA FIFRA Section 3 (40 CFR 152.25) and audited against ASTM E645-18 (Standard Test Method for Efficacy of Microbicides Used in Cooling Water and Paints). The final packaged product is a 200 kg PE drum containing NAIT 1.5% solution, supplied with a certificate of analysis confirming pH 3.8–4.2, specific gravity 1.03–1.05 at 20 °C, and absence of free chlorine. Hydrolytic stability data governing shelf-life claims are generated according to the protocol below.

What Limits Liquid Hourly Space Velocity in Continuous N-Allylisothiazolinone Synthesis?

The liquid hourly space velocity (LHSV) achievable during continuous chlorocyclisation of allyl isothiazole in a microstructured flow reactor is constrained by the competing rates of heat transfer and the formation of polyhalogenated impurities. In a Corning Advanced-Flow G1-SiC reactor plate with a total internal volume of 10 mL and a heat-transfer coefficient exceeding 1,700 W/m²·K, allyl isothiazole is fed as a 1.2 M solution in anhydrous acetonitrile at a volumetric flow rate calibrated to yield an LHSV of 2.8 h⁻¹. The chlorine stream, consisting of 0.95 M Cl₂ in glacial acetic acid pre-cooled to −10 °C via a shell-and-tube exchanger, is co-fed through a static mixer immediately upstream of the first reaction zone at a molar ratio of 1.00:1.05 (allyl isothiazole:Cl₂). Residence time across the 4-zone SiC module is held at 90 ± 3 s; the exotherm is rapidly attenuated by the integrated -oxi-cooling circuit, maintaining the process fluid at −8 °C throughout the reaction channel. Process analytical technology (PAT) relies on an inline flow-IR cell that continuously monitors the isothiazolinone carbonyl stretch at 1,665 cm⁻¹; any deviation exceeding ±2.5% from the set-point ratio triggers a diversion valve.

When LHSV surpasses 3.2 h⁻¹, the measured outlet concentration of the 4,5-dichloro-addition byproduct escalates from 0.2 wt% to 2.8 wt% within 90 s of residence-time compensation, rendering the crude unsuitable for electronic-grade formulation without an additional thin-film distillation step. Field data from a 50-tonne/annum campaign indicate that peristaltic feed pulsation exceeding ±5% of mean flow induces a pressure-drop oscillation of 0.8 bar across the SiC stack, periodically approaching the mechanical integrity limit of 18 bar and triggering an automated safety shutdown classified under IEC 61511 SIL 2. Production batches destined for semiconductor-tool cleaning fluids therefore incorporate a dual-head diaphragm pump fitted with a surge-leg damper and a downstream 0.5 µm polypropylene filter to prevent micro-plate channel blockage by adventitious particulate. The finished formulation for electronic biocide applications is a 200 ppm active NAIT solution in ultrapure water (18.2 MΩ·cm), packaged in fluorinated HDPE containers and released per ISO 14644-1 Class 5 particulate specifications alongside an ICP-MS trace-metal certificate demonstrating <1 ppb each of Na, Fe, and Cu.

Metalworking Fluid Post-Treatment Emulsion Concentrates

Allyl isothiazole-based actives are typically introduced into water-miscible metalworking fluid (MWF) concentrates not as neat compounds but as part of a pre-formulated post-treatment biocide package, predominantly to avoid the incompatibility that arises when free isothiazolinones encounter alkanolamine corrosion inhibitors. A representative formulation for semi-synthetic MWF employs an emulsion concentrate containing 5.0 wt% NAIT (derived from allyl isothiazole), 2.0 wt% sodium omadine, and 0.8 wt% 2-bromo-2-nitropropane-1,3-diol (Bronopol) solubilized in a butyl diglycol:water (3:1) solvent system. This concentrate is dosed into the circulating MWF dilution at a let-down ratio of 0.2% v/v, delivering a final active NAIT concentration of 10 ppm in the sump. Efficacy under the ASTM E2275-14 standard single-bacterial repeat-challenge protocol demonstrates a >4 log₁₀ reduction in Pseudomonas aeruginosa ATCC 9027 within 24 h at this dose level, provided that the MWF pH remains at 9.0 or below. The addition of alkanolamine buffers, particularly triethanolamine (TEA) at concentrations above 1.5%, accelerates hydrolytic ring-opening of NAIT; operators monitor this loss by tracking online oxidation-reduction potential (ORP), maintaining a value of +180 to +220 mV (Ag/AgCl) as an early-indication proxy for active-isothiazolinone depletion. The biocide package is listed on the Article 95 list under the BPR (EU) 528/2012 and must additionally meet the data requirements of Annex II of the BPR for PT 13, including a five-batch analysis of the preservative concentrate and a validated HPLC-UV method for NAIT content (LOQ 0.05 ppm in MWF matrix).

Oxidative cleavage of the allylic sidechain in allyl isothiazole yields isothiazole-5-carboxaldehyde, a pivotal intermediate in the synthesis of systemic acquired resistance (SAR) activators registered under ISO common names. In the manufacture of the dichlorinated fungicide lead isotianil, the aldehyde intermediate is produced by sparging an oxygen-ozone mixture (5% v/v O₃ in O₂) through a 0.5 M solution of allyl isothiazole in methanol:water (4:1) at −25 °C in a Corning G1-SiC ozonolysis module, achieving 92% conversion with a selectivity of 95% toward the aldehyde. The molar addition ratio of ozone to allyl isothiazole is maintained at 1.05:1.00; excess ozone is catalytically destroyed over a MnO₂-packed vent column. The resulting isothiazole-5-carboxaldehyde is immediately subjected to Pinnick oxidation with sodium chlorite (1.2 eq) and sulfamic acid scavenger at 0 °C, affording isothiazole-5-carboxylic acid, which in turn is selectively chlorinated with N-chlorosuccinimide (2.0 eq) in DMF to give 3,4-dichloroisothiazole-5-carboxylic acid—the direct pre-drug intermediate. Coupling with 2-cyanobenzamide via thionyl chloride activation completes the isotianil skeleton. The operations are conducted under ISO 9001:2015 quality management and the site master file is structured to support the chemistry, manufacturing, and controls (CMC) section of an EPA 40 CFR 180 tolerance petition. The technical-grade active ingredient, typically 96% isotianil as determined by HPLC, is formulated downstream into a 500 g/L SC (suspension concentrate) or a water-dispersible granule (WG) for foliar application at 30–50 g a.i./ha in rice blast prevention programs.

When the Isothiazole Moiety Replaces the Pyridine Ring in COX-2 Pharmacophore Design

In fragment-based drug design campaigns targeting cyclooxygenase-2 (COX-2), the allyl isothiazole scaffold has been deployed as a bioisosteric replacement for the 3-fluoropyridine ring to modulate logP and reduce CYP450 metabolic liability while retaining the key nitrogen lone-pair interaction with Arg513 in the enzyme binding pocket. The synthetic sequence for generating the screening library proceeds via a palladium-catalyzed C–H alkenylation: allyl isothiazole is reacted with ethyl 4-bromocinnamate under Pd(OAc)₂ (5 mol%), RuPhos (10 mol%), and K₂CO₃ (2.5 eq) in a 3:1 dioxane:water mixture at 110 °C for 16 h, yielding the functionalized biaryl intermediate in 68–74% isolated yields. The addition ratio in this key step stands at 1.2 equivalents of allyl isothiazole relative to the aryl bromide to compensate for competitive homo-coupling losses. Subsequent saponification and Curtius rearrangement install the sulfonamide pharmacophore, delivering the final candidate molecule with an IC₅₀ against human COX-2 of 0.8 µM in a fluorescence polarization inhibition assay conducted per the manufacturer’s kit protocol. Active pharmaceutical ingredient (API) batches intended for IND-enabling toxicology studies must be manufactured under ICH Q7 GMP guidance, with particular attention to Section 7.3 (cleaning validation) and 8.3 (process validation), and are tested for residual palladium content using USP <232> inductively coupled plasma mass spectrometry, ensuring Pd levels remain below the oral permitted daily exposure of 100 µg/day. The drug substance is micronized to a particle size D₉₀ of <10 µm and encapsulated into hydroxypropyl methylcellulose (HPMC) hard capsules for Phase I clinical evaluation.

Latex Paint Biocide Monomer and Post-Addition Shelf-Life Drift

Copolymerizable antimicrobial monomers derived from allyl isothiazole—specifically methacrylic acid 2-(isothiazol-3-yl)ethyl ester (MAIT)—are incorporated into styrene-acrylic latex binders via a seeded semi-continuous emulsion polymerization process to confer non-leaching, built-in fungal resistance to interior flat wall paints. The pre-emulsion feed consists of butyl acrylate, styrene, methacrylic acid, and MAPTAC monomer in a weight ratio of 52:43:3:2, with MAIT added as a functional co-monomer at 3.5 wt% based on total monomer. The polymerization is initiated with ammonium persulfate (0.3 wt%) and isoascorbic acid redox couple at 80 °C over a 4.5 h feed period, followed by a 45 min chase with tert-butyl hydroperoxide. Because MAIT exhibits measurable hydrolytic instability at the polymerization pH of 4.2–4.8, its incorporated molar ratio in the final latex film drifts downward during storage of the wet latex; quantitative ¹H-NMR analysis of films dried from latex aged 180 days at 25 °C shows a 22% reduction in grafted isothiazole content relative to the initial value, necessitating a titration of the biocide monomer feed to maintain a minimum 2.8 wt% active-bound isothiazole in the cured film. The resulting paint film, when tested according to ASTM D3273-21 (Standard Test Method for Resistance to Mold on the Surface of Interior Coatings in an Environmental Chamber), receives a rating of 10 (no growth) after 28 days of exposure at 32 °C and 95% RH. Additional panel testing under ASTM D5590-17 for the effect of biodeterioration on weight loss yields less than 2% mass deficit over a 4-week incubation with Aspergillus niger ATCC 9642 and Penicillium chrysogenum ATCC 11709. The formulated coating must comply with the volatile organic compound limits of EU Directive 2004/42/EC (Subcategory A/a: 30 g/L ready to use) and the safety requirements of GB 18582-2020 for interior wall materials, with the isothiazolinone extractable content limited to <15 ppm as verified by ASTM D7858-13 pressurized fluid extraction followed by LC/MS/MS. The finished latex paint is packaged in 20 L HDPE pails and distributed with a mandatory application-note warning that recoat intervals must exceed 4 h to allow sufficient oxygen inhibition for biocide surface enrichment.